IMPACT: Improving Maternal Postpartum Access to Care Through Telemedicine
NCT ID: NCT06218355
Last Updated: 2025-03-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
3500 participants
INTERVENTIONAL
2024-03-01
2028-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telehealth Multi-Component Optional Model (MOM) Study
NCT06095960
Remote Peer Support in Prevention of Postpartum Depression
NCT04639752
Maternal Mental Health Access - MaMa
NCT06049433
Social Media Intervention for Postpartum Depression
NCT02355067
Healing, Equity, Advocacy and Respect for Mamas
NCT06273436
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intensive Education
Women enrolled in the intensive education care model participate in intensive in-person education as well as ongoing virtual education via the electronic health record web portal in the form of strategically timed "pushes" of relevant and digestible educational elements via a "Care Companion." These virtual education "pushes" will include "to do" list reminders to check vital signs and submit them for review to the care team. Positive reinforcement will be provided when tasks are completed.
Intensive Education
Intervention will consist of virtual education and communication through scheduled push notifications
Enhanced Virtual Care
Women in the enhanced virtual care model will receive scheduled telehealth visits on the platform of their choice - either via video or audio-only synchronous visits. Patients in the virtual care model will check vital signs with home devices during the telehealth visit and report them directly to the provider. This "pull" approach to data collection directly contrasts with the "push" approach of comparator #1.
Enhanced Virtual Care
Intervention will utilize a telehealth model consisting of "pull" approach of patient engagement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive Education
Intervention will consist of virtual education and communication through scheduled push notifications
Enhanced Virtual Care
Intervention will utilize a telehealth model consisting of "pull" approach of patient engagement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Due to the nature of the study, all will be women, and all will be postpartum, thus of reproductive age. Postpartum women 18 years of age and older will be considered for inclusion if informed consent can be obtained.
Exclusion Criteria
* Patients with a primary language other than English or Spanish.
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Patient-Centered Outcomes Research Institute
OTHER
University of Texas Southwestern Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Elaine Duryea
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Elaine Duryea, MD
Role: PRINCIPAL_INVESTIGATOR
UT Southwestern Medical Center
David B Nelson, MD
Role: PRINCIPAL_INVESTIGATOR
UT Southwestern Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory University School of Medicine
Atlanta, Georgia, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anna Newton-Levinson, PhD, MPH
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PCORI-MMM-2022C2-27680
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
STU-2023-0332
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.